Parodi Guido, Valenti Renato, Carrabba Nazario, Memisha Gentian, Moschi Guia, Migliorini Angela, Antoniucci David
Division of Cardiology, Careggi Hospital, Florence, Italy.
Catheter Cardiovasc Interv. 2006 Jul;68(1):50-5. doi: 10.1002/ccd.20729.
To evaluate the long-term outcome of a nonoptimal result of a primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI).
An optimal PCI result was defined as TIMI flow grade 3 and residual stenosis < or = 20%. Long-term clinical follow-up (51 +/-+/- 21 months) data were collected from 1,009 consecutive patients with ST-elevation AMI who underwent primary PCI. Overall, an optimal primary PCI result was achieved in 958 patients (95%). At 5-year follow-up, patients with nonoptimal PCI had a higher rate of all-cause mortality (47% vs 19%; P < 0.00001 by log-rank test) than those with an optimal mechanical reperfusion. Fifty-two percent of the deaths in the nonoptimal PCI group occurred within the first month. Interestingly, after this period, estimated survival of 30-day alive patients was not significantly different to that of patients with an optimal PCI (P = 0.06 by log-rank test). Nonoptimal PCI result emerged as an independent predictor of 1-month mortality (OR = 3.030, 95% CI = 1.265-7.254; P = 0.013), but not of 5-year mortality. At long-term follow-up, cumulative rates of nonfatal reinfarction, hospitalization for heart failure, and additional revascularization procedures were similar between patients with nonoptimal and optimal primary PCI (4% vs 5%, P = 0.695; 4% vs 5%, P = 921; and 22% vs 20%, P = 0.816, respectively).
A nonoptimal primary PCI result represents a strong predictor of early mortality. However, in patients surviving the early phase, the incidence of clinical events at long-term follow-up seems to be similar to successfully reperfused AMI patients.
评估急性心肌梗死(AMI)患者接受直接经皮冠状动脉介入治疗(PCI)后效果未达最佳的长期预后。
PCI效果最佳定义为心肌梗死溶栓试验(TIMI)血流3级且残余狭窄≤20%。收集1009例接受直接PCI的ST段抬高型AMI连续患者的长期临床随访(51±21个月)数据。总体而言,958例患者(95%)PCI效果最佳。在5年随访时,PCI效果未达最佳的患者全因死亡率高于机械再灌注效果最佳的患者(47%对19%;对数秩检验P<0.00001)。PCI效果未达最佳组52%的死亡发生在第一个月内。有趣的是,在此期间之后,30天存活患者的预计生存率与PCI效果最佳的患者无显著差异(对数秩检验P=0.06)。PCI效果未达最佳是1个月死亡率的独立预测因素(OR=3.030,95%CI=1.265-7.254;P=0.013),但不是5年死亡率的独立预测因素。在长期随访中,PCI效果未达最佳和最佳的患者非致死性再梗死、因心力衰竭住院及再次血运重建治疗的累积发生率相似(分别为4%对5%,P=0.695;4%对5%,P=0.921;22%对20%,P=0.816)。
PCI效果未达最佳是早期死亡率的有力预测因素。然而,在度过早期阶段存活下来的患者中,长期随访时临床事件的发生率似乎与成功再灌注的AMI患者相似。